Last 19 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.27 | — | 0.12 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 3.60 | 3.62 | 2.50 | 3.05 | 3.66 | 4.50 | 5.96 | 5.71 | 4.91 | 2.81 | 2.13 | 0.99 | 1.51 |
| — | -19.5% | -58.0% | -46.7% | -25.4% | +60.0% | +179.5% | +475.4% | +225.6% | +194.9% | +75.6% | -76.4% | -20.9% | |
| P/B Ratio | 1.66 | 2.00 | 1.18 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | 14.34 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Elutia Inc.'s operating margin was -184.4% in Q1 2026, down 16.5 pp QoQ and down 53.0 pp YoY. This marks the 3rd consecutive quarter of margin compression, signaling a persistent pressure on profitability that investors should monitor. The trailing four-quarter average of -160.2% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin expanded 42.0% YoY, indicating pricing power or improving input costs.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.7% | 57.9% | 58.5% | 55.8% | 48.8% | 40.7% | 42.5% | 46.3% | 44.5% | 42.5% | 36.2% | 46.4% | 42.7% |
| — | +42.0% | +37.7% | +20.5% | +9.7% | -4.1% | +17.4% | -0.2% | +4.1% | -19.5% | -8.2% | -7.7% | +10.3% | |
| Operating Margin | -149.8% | -184.4% | -167.9% | -131.1% | -157.7% | -131.4% | -154.2% | -172.7% | -135.3% | -126.7% | -144.8% | -120.3% | -99.3% |
| — | -40.4% | -8.9% | +24.1% | -16.6% | -3.7% | -6.5% | -43.6% | -36.2% | +2.9% | -107.4% | +21.5% | -53.4% | |
| Net Margin | 434.2% | -239.9% | 2164.2% | -116.4% | -153.4% | -65.2% | -165.7% | 21.7% | -447.9% | -268.8% | -158.5% | -159.1% | -167.2% |
| — | -267.7% | +1406.0% | -636.0% | +65.7% | +75.7% | -4.5% | +113.7% | -167.9% | -115.5% | -269.1% | +6.1% | -124.9% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 192.9% | -29.8% | 255.8% | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| ROA | 108.4% | -12.7% | 154.3% | -12.2% | -26.3% | -10.4% | -21.4% | 2.8% | -72.9% | -45.7% | -19.0% | -18.2% | -18.8% |
| — | -21.8% | +819.8% | -529.4% | +64.0% | +77.2% | -12.8% | +115.6% | -287.9% | -270.8% | -126.9% | -4.8% | -12.8% | |
| ROIC | — | -3287.4% | — | — | — | — | — | — | — | — | — | — | -114.9% |
| — | — | — | — | — | — | — | — | — | — | — | — | -211.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 151.4% YoY to 2.05x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.27 | 0.27 | 0.14 | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.22 | 2.05 | 2.22 | 0.44 | 0.59 | 0.81 | 0.69 | 0.94 | 0.76 | 0.63 | 0.73 | 0.87 | 0.84 |
| — | +151.4% | +220.6% | -52.7% | -23.0% | +29.3% | -4.6% | +7.5% | -9.5% | -40.0% | -39.0% | -19.5% | -15.6% | |
| Quick Ratio | 2.12 | 1.94 | 2.12 | 0.40 | 0.45 | 0.70 | 0.59 | 0.85 | 0.68 | 0.55 | 0.64 | 0.73 | 0.63 |
| — | +177.3% | +259.3% | -53.4% | -34.4% | +27.0% | -7.5% | +16.4% | +9.2% | -29.7% | -41.6% | -12.5% | -12.9% | |
| Interest Coverage | -47.58 | -53.17 | -1.51 | -0.42 | -17.54 | -2.62 | -7.47 | 2.15 | -21.39 | -12.70 | -9.08 | -4.88 | -4.48 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 19 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ELUT stock.
Elutia Inc.'s current P/E is -1.3x. The average P/E over the last 1 quarters is 0.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Elutia Inc.'s current operating margin is -149.8%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Elutia Inc.'s business trajectory between earnings reports.